Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer.

Phase I/II Clinical Study of HRS-1738 for the Diagnosis of Prostate Cancer Patients

NCT07056439 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Positron Emission Tomography and Magnetic Resonance Imaging for Prostate Cancer

NCT00924313 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate Carcinoma

NCT00230386 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase I Clinical Study of HRS-9815 for PET/CT Imaging in Patients With Prostate Cancer

NCT06062355 ·Status: UNKNOWN ·Phase: PHASE1

Cu-64-PSMA-I&T Positron Emission Tomography (PET) Imaging of Metastatic PSMA Positive Lesions in Men With Prostate Cancer

NCT05653856 ·Status: COMPLETED ·Phase: PHASE2

PET-CT/MRI in the Radiotherapy for Prostate Cancer

NCT02816840 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

68Ga-P16-093 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients

NCT04796467 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management

NCT05799248 ·Status: RECRUITING ·Phase: PHASE3

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

NCT06056830 ·Status: RECRUITING ·Phase: PHASE3

Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer

NCT03976843 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Head-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis

NCT05955677 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

A Study of [177Lu] Lu-PSMA-XT Injection in Patients With Metastatic Prostate Cancer

NCT07096128 ·Status: RECRUITING ·Phase: PHASE1

Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection

NCT01572701 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly Diagnosed

NCT04462926 ·Status: UNKNOWN ·Phase: NA

68Ga-NOTA-RM26 PET/CT in Prostate Cancer Patients

NCT03164837 ·Status: UNKNOWN ·Phase: PHASE1

Study of Diagnostic Performance of [18F]CTT1057 in BCR

NCT04838613 ·Status: COMPLETED ·Phase: PHASE3

The Diagnostic Application of PSMAPET/MR in Patients Undergoing Secondary Prostate Puncture

NCT06901492 ·Status: NOT_YET_RECRUITING ·Phase: NA

Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer

NCT03444844 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

A Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate Cancer

NCT01615406 ·Status: COMPLETED ·Phase: PHASE1

Comparison Of DIR-MRI And DCE-MRI In Detection Of Prostate Cancer: A Pilot Study

NCT02939456 ·Status: COMPLETED ·Phase: NA

Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer

NCT06011304 ·Status: RECRUITING ·Phase: PHASE3

PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer

NCT04557501 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

68Ga-PSMA PET in the Prostate Cancer

NCT04967001 ·Status: RECRUITING ·Phase: NA

Focal Therapy for Localized Prostate Cancer

NCT03970863 ·Status: WITHDRAWN

Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate Cancer

NCT05010343 ·Status: RECRUITING ·Phase: PHASE2